Preclinical study results suggest that brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) are involved in the modulation of addictive behaviour. We investigated alterations in serum levels of BDNF and GDNF in opiate-dependent patients (28 males) who received diacetylmorphine treatment within a structured opiate maintenance programme. BDNF (T = 2.735, p = 0.009) serum levels were significantly increased in the opiate-dependent patients as compared with healthy controls (21 males), whereas GDNF serum levels (T = 1.425, p = 0.162) did not differ significantly from GDNF serum levels of the healthy controls. BDNF serum levels were significantly associated with craving for heroin (measured by the Heroin Craving Questionnaire (r = 0.420, p = 0.029) and by the General Craving Scale (r = 0.457, p = 0.016), whereas GDNF serum levels were not associated with psychometric dimensions of heroin craving. In conclusion, our results show a positive association between BDNF serum levels and opiate craving in opiate-dependent patients.
AiravaaraMPlankenAGaddnasH (2004) Increased extracellular dopamine concentrations and FosB/DeltaFosB expression in striatal brain areas of heterozygous GDNF knockout mice. Eur J Neurosci20: 2336–2344.
2.
AiravaaraMTuomainenHPiepponenTP (2007) Effects of repeated morphine on locomotion, place preference and dopamine in heterozygous glial cell line-derived neurotrophic factor knockout mice. Genes Brain Behav6: 287–298.
3.
AkaneyaYTakahashiMHatanakaH (1995) Selective acid vulnerability of dopaminergic neurons and its recovery by brain-derived neurotrophic factor. Brain Res704: 175–183.
4.
AltarCABoylanCBJacksonC (1992) Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo. Proc Natl Acad Sci USA89: 11,347–11,351.
5.
AngelucciFRicciVPomponiM (2007) Chronic heroin and cocaine abuse is associated with decreased serum concentrations of the nerve growth factor and brain-derived neurotrophic factor. J Psychopharmacol21: 820–825.
6.
BusBATendolkarIFrankeB (2011) Serum brain-derived neurotrophic factor: Determinants and relationship with depressive symptoms in a community population of middle-aged and elderly people. World J Biol Psychiatry00: 00–00.
7.
ChengCYHongCJYuYW (2005) Brain-derived neurotrophic factor (Val66Met) genetic polymorphism is associated with substance abuse in males. Brain Res Mol Brain Res140: 86–90.
8.
DucrayAKrebsSHSchallerB (2006) GDNF family ligands display distinct action profiles on cultured GABAergic and serotonergic neurons of rat ventral mesencephalon. Brain Res1069: 104–112.
9.
FilipMFaron-GoreckaAKusmiderM (2006) Alterations in BDNF and trkB mRNAs following acute or sensitizing cocaine treatments and withdrawal. Brain Res1071: 218–225.
10.
GhitzaUEZhaiHWuP (2010) Role of BDNF and GDNF in drug reward and relapse: A review. Neurosci Biobehav Rev35: 157–171.
11.
GrahamDLEdwardsSBachtellRK (2007) Dynamic BDNF activity in nucleus accumbens with cocaine use increases self-administration and relapse. Nat Neurosci10: 1029–1037.
12.
HeberleinALenzBMuschlerM (2010) BDNF plasma levels decrease during benzodiazepine withdrawal in patients suffering from comorbidity of depressive disorder and benzodiazepine dependence. Psychopharmacology209: 213–213.
13.
JohnsonSWNorthRA (1992) Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci12: 483–488.
14.
KaregeFSchwaldMCisseM (2002) Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett328: 261–264.
15.
KleinABWilliamsonRSantiniMA (2010) Blood BDNF concentrations reflect brain-tissue BDNF levels across species. Int J Neuropsychopharmacol1–7.
16.
LuLDempseyJLiuSY (2004) A single infusion of brain-derived neurotrophic factor into the ventral tegmental area induces long-lasting potentiation of cocaine seeking after withdrawal. J Neurosci24: 1604–1611.
17.
LuLWangXWuP (2009) Role of ventral tegmental area glial cell line-derived neurotrophic factor in incubation of cocaine craving. Biol Psychiatry66: 137–145.
18.
MesserCJEischAJCarlezonJrWA (2000) Role for GDNF in biochemical and behavioral adaptations to drugs of abuse. Neuron26: 247–257.
19.
NiwaMNittaAYamadaK (2007) The roles of glial cell line-derived neurotrophic factor, tumor necrosis factor-alpha and an inducer of these factors in drug dependence. J Pharmacol Sci104: 116–121.
20.
NumanSLane-LaddSBZhangL (1998) Differential regulation of neurotrophin and trk receptor mRNAs in catecholaminergic nuclei during chronic opiate treatment and withdrawal. J Neurosci18: 10,700–10,708.
21.
PedersenLMJacobsenLMMollerupS (2010) Spinal cord long-term potentiation (LTP) is associated with increased dorsal horn gene expression of IL-1beta GDNF and iNOS. Eur J Pain14: 255–260.
22.
SaundersJBAaslandOGBaborTF (1993) Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption – II. Addiction88: 791–804.
23.
SpanagelRWeissF (1999) The dopamine hypothesis of reward: Past and current status. Trends Neurosci22: 521–527.
24.
StratenGEschweilerGWMaetzlerW (2009) Glial cell-line derived neurotrophic factor (GDNF) concentrations in cerebrospinal fluid and serum of patients with early Alzheimer's disease and normal controls. J Alzheimers Dis18: 331–337.
25.
TiffanySTCarterBLSingletonEG (2000) Challenges in the manipulation, assessment and interpretation of craving relevant variables. Addiction95 (Suppl 2): S177–S187.
26.
TomacAWidenfalkJLinLF (1995) Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult. Proc Natl Acad Sci USA92: 8274–8278.
